Bertelmann T, Heun C, Paul C, Bari-Kacik E, Sekundo W, Schulze S
Department of Ophthalmology, Philipps-University Marburg, Baldingerstraße, 35043 Marburg, Germany.
J Ophthalmol. 2015;2015:807389. doi: 10.1155/2015/807389. Epub 2015 Nov 30.
Purpose. To evaluate whether prophylactic circumferential retinal cryopexy (CRC) can prevent pseudophakic retinal detachment (PRD) development after posterior capsule rupture (PCR) during phacoemulsification. Methods. Retrospective patient chart analysis of eyes experiencing a PCR during phacoemulsification. Comparison of PRD development between eyes receiving CRC (cryo+ group) or not (cryo- group). Results. Overall 106 patients were analyzed, thereof 61 (58%) in the cryo+ and 45 (42%) in the cryo- group. In both clusters a total of 10 PRDs (9.4%) occurred, thereof 3 (30%) in the cryo+ as well as 7 (70%) in the cryo- group (p = 0.087), 79.8 ± 81.58 weeks after PCR. Relative/absolute risk reduction in CRC-treated eyes was calculated to be 68%/11%. Prophylactic CRC reduced PRD development 0.3-fold. Number needed to treat was estimated to be 9.4. Conclusion. Prophylactic CRC might be a useful treatment option in eyes with PCR to hamper PRD development in the further course. Further research is indicated to evaluate this beneficial effect between eyes with and without a rupture of the anterior vitreous cortex and accompanying vitreous loss in an expanding number of eyes.
目的。评估预防性环形视网膜冷冻术(CRC)能否预防白内障超声乳化术中后囊破裂(PCR)后人工晶状体性视网膜脱离(PRD)的发生。方法。对白内障超声乳化术中发生PCR的患者病历进行回顾性分析。比较接受CRC治疗的眼(冷冻治疗组)和未接受CRC治疗的眼(非冷冻治疗组)中PRD的发生情况。结果。共分析了106例患者,其中冷冻治疗组61例(58%),非冷冻治疗组45例(42%)。两组中共发生10例PRD(9.4%),冷冻治疗组3例(30%),非冷冻治疗组7例(70%)(p = 0.087),发生于PCR后79.8 ± 81.58周。计算CRC治疗眼的相对/绝对风险降低率分别为68%/11%。预防性CRC使PRD的发生减少了0.3倍。估计治疗所需人数为9.4。结论。预防性CRC可能是一种有用的治疗选择,可用于预防PCR眼后续发生PRD。需要进一步研究以评估在更多眼中,前玻璃体皮质破裂伴玻璃体丢失和不伴这些情况的眼中这种有益效果。